KOOL - Cesca Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cesca Therapeutics Inc.

2711 Citrus Road
Rancho Cordova, CA 95742
United States
916-858-5100
http://www.cescatherapeutics.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees70

Key Executives

NameTitlePayExercisedAge
Mr. Jeff CaublePrincipal Financial & Accounting OfficerN/AN/A45
Ms. Vivian H. LiuCOO, Corp. Sec. & DirectorN/AN/A56
Dr. Xiaochun Xu Ph.D.Chairman of Board & CEO9kN/A47
Mr. Joseph BalagotSr. VP of Corp. Devel.N/AN/AN/A
Dr. Venkatesh Ponemone Ph.D., F.A.C.G.Exec. Director of India Operations and Director of Clinical & Scientific AffairsN/AN/A42
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.

Corporate Governance

Cesca Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.